Brain Cancer
2 competing products in clinical development for Brain Cancer.
Pipeline by Phase
Phase 21
Phase 31
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Nivolumab + Temozolomide | Ono Pharmaceutical | Phase 3 | Completed | 40 |
| Palonosetron (Aloxi) and Dexamethasone | Eisai | Phase 2 | Terminated | 27 |